David Hale
Board Member
Dermata Therapeutics, Inc. (DRMA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Hale
David Hale is recorded as Board Member at Dermata Therapeutics, Inc. (DRMA). Dermata Therapeutics, Inc. reported in an 8-K filed May 27, 2026 that David Hale was appointed Class II director. Dermata Therapeutics, Inc. reported in an 8-K filed August 3, 2023 that David Hale was appointed Class II director, effective August 3, 2023.
“The stockholders elected David Hale, Steven Mento, Ph.D. and Brittany Bradrick as Class II directors to serve until the 2029 annual meeting and until their successors have been duly elected and qualified.”
“The election of David Hale, Steven Mento, and Brittany Bradrick as Class II directors to hold office for a term of three years, until their successor is duly elected and qualified or they are otherwise unable to complete their term.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-27–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Dermata Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Gerald T. Proehl CEO, Board Member
- Kyri K. Van Hoose CFO
- Kyri Van Hoose CFO
- Andrew Sandler Board Member
- Brittany Bradrick Board Member
- Kathleen Scott Board Member
- Steven Mento Board Member
- Steven Mento, Ph.D. Board Member
- To approve Board Member
- Wendell Wierenga Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.